Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod.
An official website of the United States government
A .gov website belongs to an official government organization in the United States.
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
The U.S. Food and Drug Administration authorized an extension to the shelf life for certain lots of COVID-19 therapeutic products. The following table lists the original dates and, if applicable, extension expiration dates for the following COVID-19 therapeutic products: bamlanivimab, bebtelovimab, etesevimab, Evusheld, Lagevrio (molnupiravir), REGEN-COV, and sotrovimab.
As of March 9, 2024, EUA-labeled Paxlovid (nirmatrelvir co-packaged with ritonavir) no longer authorized for use, regardless of expiry data.
Learn more about shelf-life extensions and other COVID-19 therapeutic information in the Important Updates.
Download All Entries 33KB XLS